FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between ixigo IPO and Kronox Lab Sciences IPO.
ixigo IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Kronox Lab Sciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
ixigo IPO | Kronox Lab Sciences IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Jm Financial Limited |
Pantomath Capital Advisors Pvt Ltd |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ixigo IPO is up to ₹740.10 Cr whereas the issue size of the Kronox Lab Sciences IPO is up to ₹130.15 Cr. The final issue price of ixigo IPO is ₹93.00 per share and of Kronox Lab Sciences IPO is ₹136.00 per share.
ixigo IPO | Kronox Lab Sciences IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹88.00 per share | ₹129.00 per share |
Issue Price (Upper) | ₹93.00 per share | ₹136.00 per share |
Issue Price (Final) | ₹93.00 per share | ₹136.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 161 shares | 110 shares |
Fresh Issue Size | 1,29,03,226 shares | |
Fresh Issue Size (Amount) | up to ₹120.00 Cr | |
OFS Issue Size | 6,66,77,674 shares | 95,70,000 shares |
OFS Issue Size (Amount) | up to ₹620.10 Cr | up to ₹130.15 Cr |
Issue Size Total | 7,95,80,900 shares | 95,70,000 shares |
Issue Size Total (Amount) | up to ₹740.10 Cr | up to ₹130.15 Cr |
ixigo IPO opens on Jun 10, 2024, while Kronox Lab Sciences IPO opens on Jun 03, 2024. The closing date of ixigo IPO and Kronox Lab Sciences IPO is Jun 12, 2024, and Jun 05, 2024, respectively.
ixigo IPO | Kronox Lab Sciences IPO | |
---|---|---|
Anchor Bid Date | Jun 07, 2024 | May 31, 2024 |
Issue Open | Jun 10, 2024 | Jun 03, 2024 |
Issue Close | Jun 12, 2024 | Jun 05, 2024 |
Basis Of Allotment (Tentative) | Jun 13, 2024 | Jun 06, 2024 |
Initiation of Refunds (Tentative) | Jun 14, 2024 | Jun 07, 2024 |
Credit of Share (Tentative) | Jun 14, 2024 | Jun 07, 2024 |
Listing date (Tentative) | Jun 18, 2024 | Jun 10, 2024 |
Anchor Lockin End date 1 | Jul 13, 2024 | Jul 06, 2024 |
Anchor Lockin End date 2 | Sep 11, 2024 | Sep 04, 2024 |
ixigo IPO P/E ratio is 148.87, as compared to Kronox Lab Sciences IPO P/E ratio of 30.37.
ixigo IPO | Kronox Lab Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Le Travenues Technology Limited Financial Information (Restated Consolidated)Le Travenues Technology Limited's revenue increased by 34.46% and profit after tax (PAT) rose by 210.91% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Kronox Lab Sciences Limited Financial Information (Restated)Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 148.87 | 30.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹3603.04 Cr. | ₹504.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 25.66%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.15%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹0.62 | ₹4.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 15.26%% | 25.66%% |
In the ixigo IPO retail investors (RII) are offered 79,58,089 shares while in Kronox Lab Sciences IPO retail investors are offered 79,58,089 shares. Qualified institutional buyers (QIB) are offered 2,38,74,271 shares in ixigo IPO and 19,14,000 shares in Kronox Lab Sciences IPO.
ixigo IPO | Kronox Lab Sciences IPO | |
---|---|---|
Anchor Investor Reserveration | 3,58,11,405 shares | 28,71,000 shares |
Market Maker Reserveration | ||
QIB | 2,38,74,271 shares | 19,14,000 shares |
NII | 1,19,37,134 shares | 14,35,500 shares |
RII | 79,58,089 shares | 33,49,500 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 4,37,69,494 shares | 66,99,000 shares |
ixigo IPO subscribed 98.10x in total, whereas Kronox Lab Sciences IPO subscribed 117.25x.
ixigo IPO | Kronox Lab Sciences IPO | |
---|---|---|
QIB (times) | 106.73x | 89.03x |
NII (times) | 110.25x | 301.92x |
Big NII (times) | 117.40x | 322.26x |
Small NII (times) | 95.95x | 261.22x |
RII (times) | 53.95x | 54.24x |
Employee (times) | ||
Other (times) | ||
Total (times) | 98.10x | 117.25x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|